Gender and Race Differences in HeartMate3 Left Ventricular Assist Device as a Bridge to Transplantation.

ABSTRACT:

Background

Gender and racial disparities exist after left ventricular assist device (LVAD) implantation. Compared with older devices, the HeartMate 3 (HM3) (Abbott Cardiovascular) has demonstrated improved survival. Whether HM3 differentially improves outcomes by gender or race and ethnic groups is unknown.

Objectives

The purpose of this study is to examine differences by gender and race in the use of HM3 among patients listed for heart transplantation (HT) and associated waitlist and post-transplant outcomes.

Methods

The authors examined all patients (20% women, 33% Black) who received LVADs as bridge to transplantation (BTT) between January 2018 and June 2020, in the OPTN (Organ Procurement and Transplantation Network) database. Trends in use of HM3 were evaluated b

SUBMITTER: Steinberg RS 

PROVIDER: S-EPMC12455850 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature